Topics

PubMed Journals Articles About "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" RSS

02:14 EDT 16th September 2019 | BioPortfolio

MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase articles that have been published worldwide.

More Information about "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" on BioPortfolio

We have published hundreds of MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase news stories on BioPortfolio along with dozens of MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase Clinical Trials and PubMed Articles about MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase Companies in our database. You can also find out about relevant MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase Drugs and Medications on this site too.

Showing "MorphoSys MorphoSys Biopharma Announce First Patient Dosed Phase" PubMed Articles 1–25 of 17,000+

Phase of Care Mortality Analysis According to Individual Patient Risk Profile.

Phase of Care Mortality Analysis (POCMA) is a quality improvement tool categorizing triggers for mortality into phases of patient care. The relationship between a patient's risk-profile and the triggers for mortality, however, is incompletely understood.


Investigating the bioavailabilities of olerciamide A via the rat's hepatic, gastric and intestinal first-pass effect models.

Olerciamide A (OA), as a new alkaloid isolated from Portulaca oleracea L., has been proved to possess a low bioavailability (F) after oral administration in rats in our previous study. Hence, to clarify the reasons of its low bioavailability, the hepatic, gastric and intestinal first-pass effect models were established, and a rapid, sensitive UHPLC method were validated and applied for the determination after dosed via femoral, portal, gastric and intestinal routes.. Being the inhibitors of CYP3A and P-gp, ...

Development of 5-aminopyrazole-4-carboxamide-based bumped-kinase inhibitors for Cryptosporidiosis therapy.

Cryptosporidium is a leading cause of pediatric diarrhea worldwide. Currently there is neither a vaccine nor a consistently effective drug available for this disease. Selective 5-aminopyrazole-4-carboxamide-based bumped-kinase inhibitors (BKIs) are effective in both in vitro and in vivo models of Cryptosporidium parvum. Potential cardiotoxicity in some BKIs led to the continued exploration of the 5-aminopyrazole-4-carboxamide scaffold to find safe and effective drug candidates for Cryptosporidium. A series ...


Complex therapies for advanced Parkinson's disease: what is the role of doctor-patient communication?

Communication processes play a key role in the patient-doctor relationship. Few studies have considered communicative processes in advanced Parkinson's disease (PD), and in particular in the phase of proposing complex therapies (CT). Therefore, we explored the role of communication and patient-doctor relationship in the transition phase to CT for advanced PD, analysing satisfaction, factors influencing the relationship and patients' unmet needs.

Correction to: Revefenacin: First Global Approval.

The article Revefenacin: First Global Approval, written by Young-A Heo, was originally published Online First without open access. After publication in volume 79, issue 1, pages 85-91, Mylan Inc. (Canonsburg, Pennsylvania, USA) and Theravance Biopharma US, Inc. (South San Francisco, California, USA) requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Mylan Inc. (Canonsburg, Pennsylvania, USA) and Theravance Biopharma US, Inc. (...

The Current Indications for Non-Surgical Treatment of Hypopharyngeal Cancer.

The management of hypopharyngeal cancer is challenging because of poor patient survival and the potential effects of treatment on breathing, voice and swallowing. In general, early stage hypopharyngeal cancer can be primarily treated by radiotherapy or conservative transoral or open surgery, whereas advanced stage hypopharyngeal cancer can be treated by non-surgical protocols if the patient has no loss of functions (dysfunctional larynx) and/or cartilage invasion (T4a). Factors to determine individualized p...

Clinical treatment of necrotizing ulcerative gingivitis: a case report with 10-year follow-up.

The aim of this case report is to describe the diagnosis and treatment of a patient with necrotizing ulcerative gingivitis. An 18-year-old man with no systemic problems reported with chief complaints of gingival bleeding during toothbrushing and spontaneous pain. Clinical examination revealed significant plaque accumulation on the surfaces of all teeth as well as papillary necrosis involving mainly the anterior teeth. Treatment included an initial phase of supragingival plaque and calculus removal along wit...

Effects of norepinephrine and vasopressin discontinuation order in the recovery phase of septic shock: a systematic review and individual patient data meta-analysis.

The impact of vasopressin and norepinephrine discontinuation order in the recovery phase of septic shock remains controversial. This systematic review and patient-level meta-analysis was performed to determine the impact of vasopressin and norepinephrine discontinuation order on clinically significant outcomes in the recovery phase of septic shock.

Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.

This multicenter, open-label phase 1/2 study evaluated single-agent carfilzomib in 50 heavily pretreated Japanese patients with relapsed/refractory multiple myeloma (median of five prior treatments). In phase 1, patients were dosed at three levels: 15 mg/m , 20 mg/m , or 20/27 mg/m . The maximum tolerated dosage was not reached at the tolerability evaluation. The patients in phase 2 were treated with 20/27 mg/m carfilzomib. The median duration of exposure to carfilzomib in the 20/27 mg/m group at this final...

Letter to the editor: Oral hygiene phase revisited. How different study designs have affected results in intervention studies.

Every periodontal researcher have been taught, and every textbook in periodontics have advocated, that a phase in which the patient is meticulously motivated and instructed in proper oral hygiene - the oral hygiene phase - must be included in any periodontal intervention. However, how is this oral hygiene phase actually portrayed in periodontal intervention studies, and how much space have this important phase received in the planning and carry-through of intervention studies? The purpose of this letter to ...

Migrants and refugees: Improving health and well-being in a world on the move.

The PLOS Medicine Editors discuss migrant and refugee health, and announce a forthcoming special issue devoted to the topic.

Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich's Ataxia.

Friedreich's Ataxia (FA) is an inherited neurodegenerative disorder resulting from decreased expression of the mitochondrial protein frataxin, for which there is no approved therapy. High throughput screening of clinically used drugs identified Dimethyl fumarate (DMF) as protective in FA patient cells. Here we demonstrate that DMF significantly increases frataxin gene (FXN) expression in FA cell model, FA mouse model and in DMF treated humans. DMF also rescues mitochondrial biogenesis deficiency in FA-patie...

The need for an adapted initiation nomogram during Fiix prothrombin time monitoring of warfarin.

The new Fiix prothrombin time (Fiix-PT) and its derived Fiix-normalized ratio (Fiix-NR) is affected only by reductions in coagulation factors (F) II and X, the two factors responsible for the antithrombotic effect of vitamin K antagonists (VKA). Due to insensitivity to reductions in the short half-life FVII, the Fiix-NR rises later than standard PT-INR during warfarin initiation. To describe a warfarin initiation nomogram adapted for monitoring with Fiix-NR, anticoagulation development was assessed during u...

The Patient's Role in Patient Safety.

Keeping patients safe while they receive medical care is essential. Yet current systems designed to ensure patient safety are not enough, because medical error is the third leading cause of preventable deaths in the United States. Clinicians can partner with the patient to enhance patient safety. Pulse Center for Patient Safety proposes patient- and family-driven processes designed to improve a patient's chances of avoiding harm. This article discusses highlights of the role of patient safety through a gras...

Native and Denaturing MS Protein Deconvolution for Biopharma: Monoclonal Antibodies and Antibody-Drug-Conjugates to Polydisperse Membrane Proteins and Beyond.

Electrospray ionization mass spectrometry (ESI-MS) is a ubiquitously used analytical method applied across multiple departments in biopharma, ranging from early Research Discovery to Process Development. Accurate, efficient and consistent protein MS spectral deconvolution across multiple instrument and detector platforms (ToF, Orbitrap, FT-ICR) is essential. When proteins are ionized during the ESI process, a distribution of consecutive multiply charged ions are observed on the m/z scale, either positive (M...

DNA damage triggers increased mobility of chromosomes in G1 phase cells.

During S phase in chromosomal loci become mobile in response to DNA double-strand breaks both at the break site (local mobility) and throughout the nucleus (global mobility). Increased nuclear exploration is regulated by the recombination machinery and the DNA damage checkpoint, and is likely an important aspect of homology search. While mobility in response to DNA damage has been studied extensively in S phase, the response in interphase has not, and the question of whether homologous recombination procee...

Waking Up and Smelling the Coffee: Inducing Olfactory Function with 3-Phase Auricular Therapy.

Loss of the sense of smell, from both known and unknown causes, can be refractory to medical intervention. Cases unrelated to head trauma or infection might be ignored or assumed to be untreatable. A 20-year-old male had lifelong anosmia. This patient received a single session of 3-phase auricular therapy (3PAT), including electrical stimulation and insertion of 3-mm, semipermanent ear acupuncture needles, covered by surgical tape and adhesive. Approximately 1 month following insertion of the acupuncture ...

Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF or BRAF mutations treated with adjuvant dabrafenib plus trametinib (COMBI-AD): a randomised, placebo-controlled, phase 3 trial.

In the phase 3 COMBI-AD study, patients with resected, stage III melanoma with BRAF or BRAF mutations received adjuvant dabrafenib plus trametinib or placebo. The primary analysis showed that dabrafenib plus trametinib significantly improved relapse-free survival at 3 years. These results led to US Food and Drug Administration approval of dabrafenib plus trametinib as adjuvant treatment for patients with resected stage III melanoma with BRAF or BRAF mutations. Here, we report the patient-reported outcomes f...

Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.

The demographics and management of patients with multiple sclerosis (MS) differ across geographical regions, but it is unclear whether/how these differences affect treatment outcomes. The aim of this post-hoc analysis was to assess teriflunomide use and patient-reported outcomes in the United States (US) and the rest of the world (ROW) in the phase 4 Teri-PRO study (NCT01895335).

Room temperature electrofreezing of water yields a missing dense ice phase in the phase diagram.

Water can freeze into diverse ice polymorphs depending on the external conditions such as temperature (T) and pressure (P). Herein, molecular dynamics simulations show evidence of a high-density orthorhombic phase, termed ice χ, forming spontaneously from liquid water at room temperature under high-pressure and high external electric field. Using free-energy computations based on the Einstein molecule approach, we show that ice χ is an additional phase introduced to the state-of-the-art T-P phase diagram....

CDx, NGS and regulation: five perspectives from the Pistoia Alliance.

Companion diagnostics (CDx) are essential to the practice of precision medicine. Next-generation sequencing is an increasingly important tool in the development of CDx. However, for CDx to be deployed, many different biopharma industry sectors need to collaborate. This paper outlines some of the challenges and opportunities perceived by the biopharmaceutical industry, the Europe Molecular Quality Network, a regulatory agency, a notified body and a CDx service provider.

Case studies in neuroscience: Subcortical origins of the frequency-following response.

The auditory frequency-following response (FFR) reflects synchronized and phase-locked activity along the auditory pathway in response to sound. While historically thought to reflect subcortical activity, recent evidence suggests an auditory cortex contribution as well. Here we present electrophysiological evidence for the FFR's origins from two cases: a patient with bilateral auditory cortex lesions and a patient with auditory neuropathy, a condition of subcortical origin. The patient with auditory cortex ...

Gynecologic Surgical Outcomes Through the Patient's Eyes: Are Physicians Looking in the Same Direction?

Patient-centered care integrates the highest clinical standards with patient preferences surrounding their treatment. Increasing focus is being placed on the identification of patient-centered outcomes to optimize the impact of medical treatments on patient quality of life, as defined by patients themselves.

Patient perspectives and treatment regret after de-escalated chemoradiation for human papillomavirus-positive oropharyngeal cancer: Findings from a phase II trial.

We evaluated priorities, expectations, and regret among patients treated on a phase II trial of de-escalated chemoradiation for human papillomavirus (HPV)-positive oropharyngeal cancer.

Structural phase transitions in malononitrile, CH2(CN)2: crystal structure of the δ phase by neutron powder diffraction, and ab initio calculations of the structures and phonons of the α and δ phases.

The crystal structure of the low-temperature δ phase of crystalline malononitrile, CH2(CN)2 (stable phase below 260 K), has been determined using Rietveld refinement on neutron powder diffraction data. The δ phase has a slightly lower density than the other three low-pressure phases, and unlike those phases it has a polar structure. The reconstructive transition from the β to δ phase involves a major reconstruction of the structure, including establishing a network of hydrogen bonds. DFT simulations of ...


Quick Search